SEC Form 4 · accession 0001209191-15-044595
SOLENO THERAPEUTICS INC · SLNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ernest Mario
Director · 10% Owner
Period of report
May 15, 2015
Accepted (ET)
May 19, 2015 · 6:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001484565
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock OptionF1 | $4.66 | May 15, 2015 | A | 5,000 | A | May 15, 2016 | May 15, 2025 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1One hundred percent (100%) of the shares subject to the option shall be vested on the earlier of one-year from the grant date of May 15, 2015, or the day prior to the Company's annual stockholder meeting in 2016; subject to Optionee's continuing to be a Service Provider on such dates.